TY - JOUR T1 - Continuing inequalities in COVID-19 mortality in England and Wales, and the changing importance of regional, over local, deprivation JF - medRxiv DO - 10.1101/2022.01.28.22270022 SP - 2022.01.28.22270022 AU - Gareth J Griffith AU - Gwilym Owen AU - David Manley AU - Laura D Howe AU - George Davey Smith Y1 - 2022/01/01 UR - http://medrxiv.org/content/early/2022/01/29/2022.01.28.22270022.abstract N2 - Background Observational studies have highlighted that where individuals live is far more important for risk of dying with COVID-19, than for dying of other causes. Deprivation is commonly proposed as explaining such differences. During the period of localised restrictions in late 2020, areas with higher restrictions tended to be more deprived. We explore how this impacted the relationship between deprivation and mortality and see whether local or regional deprivation matters more for inequalities in COVID-19 mortality.Methods We use publicly available population data on deaths due to COVID-19 and all-cause mortality between March 2020 and April 2021 to investigate the scale of spatial inequalities. We use a multiscale approach to simultaneously consider three spatial scales through which processes driving inequalities may act. We go on to explore whether deprivation explains such inequalities.Results Adjusting for population age structure and number of care homes, we find highest regional inequality in October 2020, with a COVID-19 mortality rate ratio of 5.86 (95% CI 3.31 to 19.00) for the median between-region comparison. We find spatial context is most important, and spatial inequalities higher, during periods of low mortality. Almost all unexplained spatial inequality in October 2020 is removed by adjusting for deprivation. During October 2020, one standard deviation increase in regional deprivation was associated with 2.45 times higher local mortality (95% CI, 1.75 to 3.48).Conclusions Spatial inequalities are greatest in periods of lowest overall mortality, implying that as mortality declines it does not do so equally. During the prolonged period of low restrictions and low mortality in summer 2020, spatial inequalities strongly increased. Contrary to previous months, we show that the strong spatial patterning during autumn 2020 is almost entirely explained by deprivation. As overall mortality declines, policymakers must be proactive in detecting areas where this is not happening, or risk worsening already strong health inequalities.Key messages- Spatial inequalities in local mortality are highest in periods of lower overall mortality.- Spatial inequality in COVID-19 mortality peaked in October 2020, before decreasing strongly in November and over the winter period.- Deprivation explains almost all inequality during October when inequality was at its highest.- Regional deprivation was far more strongly associated with local mortality than local deprivation during September to November 2020.- This is consistent with an overdispersed distribution of secondary infections governed by transmission heterogeneity structured by deprivation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe Medical Research Council (MRC) and the University of Bristol support the MRC Integrative Epidemiology Unit [MC_UU_00011/1, MC_UU_00011/3].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Source data are all openly available - as documented in "Data Availability"I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online: ONS Deaths due to COVID-19 mortality data are available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/deathsduetocovid19bylocalareaanddeprivation ONS Deaths involving COVID-19 mortality data are available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/deathsinvolvingcovid19bylocalareaanddeprivation ONS Administrative geographical identifiers are available at: https://geoportal.statistics.gov.uk ONS population health estimates are available at: https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/middlesuperoutputareamidyearpopulationestimates. ESRI care home estimates are available at: https://covid19.esriuk.com/datasets/e4ffa672880a4facaab717dea3cdc404_0 Equivalised UK IMD estimates are available at: https://github.com/mysociety/composite_uk_imd All code to reproduce analyses is available at: www.github.com/zimbabwelsh/covid_mort_spatseg ER -